Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Aquarius Surgical Technologies Inc

Healthcare US AQQRF

0.0042USD
0.00(0%)

Last update at 2026-06-18T13:30:00Z

Day Range

0.00420.0042
LowHigh

52 Week Range

0.00420.0042
LowHigh

Fundamentals

  • Previous Close 0.0042
  • Market Cap0.12M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.29828M
  • Revenue TTM0.08M
  • Revenue Per Share TTM0.003
  • Gross Profit TTM 0.04M
  • Diluted EPS TTM-0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Income before tax -1.16573M -0.74862M -0.72344M -0.85920M -1.81041M
Minority interest - - - - -
Net income -1.16725M -0.75766M -0.72344M -0.85920M -1.81041M
Selling general administrative 0.23M 0.26M 0.46M 0.77M 0.87M
Selling and marketing expenses 0.33M 0.33M 0.26M 0.21M 0.32M
Gross profit 0.05M 0.13M 0.08M 0.13M 0.22M
Reconciled depreciation 0.03M 0.03M 0.00779M 0.05M 0.14M
Ebit -0.86196M -0.46075M -0.66445M -0.68784M 0.24M
Ebitda -0.83281M -0.42987M -0.65666M -0.63677M 0.38M
Depreciation and amortization 0.03M 0.03M 0.00779M 0.05M 0.14M
Non operating income net other - - - - -
Operating income -0.54556M -0.45873M -0.66445M -0.68784M 0.24M
Other operating expenses 0.64M 0.69M 0.86M 1.02M 1.38M
Interest expense 0.30M 0.29M 0.20M 0.20M 0.00000M
Tax provision 0.00151M 0.00904M - - -
Interest income 0.00055M 0.00173M 0.00621M 0.01M 0.01M
Net interest income -0.31592M -0.25940M -0.21261M -0.19914M 0.01M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.00151M 0.00904M 0.20M 0.20M 1.02M
Total revenue 0.09M 0.21M 0.20M 0.33M 0.58M
Total operating expenses 0.59M 0.62M 0.73M 0.82M 1.01M
Cost of revenue 0.04M 0.07M 0.12M 0.20M 0.37M
Total other income expense net -0.62018M -0.28989M 0.14M 0.03M -1.03239M
Discontinued operations - - - - -
Net income from continuing ops -1.16725M -0.75766M -0.72344M -0.85920M -1.81041M
Net income applicable to common shares - - -0.72344M -0.85920M -1.81041M
Preferred stock and other adjustments - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 1.95M 0.57M 0.68M 0.89M 0.95M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.02M 0.03M 0.03M 0.05M 0.02M
Total liab 7.72M 5.18M 4.53M 4.11M 3.34M
Total stockholder equity -5.77280M -4.60556M -3.84790M -3.21486M -2.39466M
Deferred long term liab - - - - -
Other current liab - 1.02M - 0.72M 0.41M
Common stock 19.95M 19.95M 19.95M 19.87M 19.84M
Capital stock 19.95M 19.95M 19.95M 19.87M 19.84M
Retained earnings -35.04197M -33.87472M -33.11706M -32.39362M -31.53443M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -0.00000M
Cash 0.00756M 0.11M 0.12M 0.16M 0.15M
Cash and equivalents - - - - -
Total current liabilities 1.74M 1.87M 1.51M 1.65M 1.00M
Current deferred revenue - - - - -
Net debt 6.46M 3.93M 3.39M 3.08M 2.78M
Short term debt 0.49M 0.74M 0.50M 0.78M 0.58M
Short long term debt 0.46M 0.71M 0.47M 0.78M 0.58M
Short long term debt total 6.47M 4.04M 3.51M 3.24M 2.93M
Other stockholder equity 9.32M 9.32M 9.32M 9.30M 9.30M
Property plant equipment - - 0.10M 0.00551M 0.30M
Total current assets 0.10M 0.19M 0.27M 0.61M 0.64M
Long term investments 1.80M 0.30M 0.30M 0.28M 0.00000M
Net tangible assets - - -3.84790M -3.21486M -2.39466M
Short term investments - - - - -
Net receivables 0.05M 0.03M 0.08M 0.35M 0.46M
Long term debt 5.96M 3.25M 2.93M 2.46M 0.23M
Inventory 0.02M 0.02M 0.04M 0.04M 0.02M
Accounts payable 1.25M 0.12M 1.02M 0.15M 0.41M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 1.85M 0.38M 0.41M 0.29M 0.30M
Capital lease obligations 0.05M 0.08M 0.11M - -
Long term debt total - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Investments -1.80000M -0.00436M 0.00000M -0.00522M -0.10000M
Change to liabilities - - 0.35M 0.46M 0.09M
Total cashflows from investing activities -1.80000M -0.00436M - -0.00522M -0.10000M
Net borrowings -0.17103M -0.08571M -0.08919M 0.15M 0.68M
Total cash from financing activities 2.08M 0.24M -0.11322M 0.13M 0.55M
Change to operating activities - - 0.33M -0.04882M 0.01M
Net income -1.16725M -0.75766M -0.72344M -0.85920M -1.81041M
Change in cash -0.09982M -0.01464M -0.03617M 0.01M 0.04M
Begin period cash flow 0.11M 0.12M 0.16M 0.15M 0.11M
End period cash flow 0.00756M 0.11M 0.12M 0.16M 0.15M
Total cash from operating activities -0.38329M -0.25256M 0.08M -0.10884M -0.40900M
Issuance of capital stock - - - - -
Depreciation 0.03M 0.03M 0.00779M 0.05M 0.14M
Other cashflows from investing activities - - - - -
Dividends paid - 0.00000M 0.00000M - -
Change to inventory -0.00232M 0.03M 0.00083M -0.02344M 0.08M
Change to account receivables -0.00127M 0.03M 0.01M 0.12M -0.05795M
Sale purchase of stock - - - 0.00000M -0.00009M
Other cashflows from financing activities 2.25M 0.30M -0.00089M 0.26M 0.62M
Change to netincome - - 0.11M 0.19M 1.10M
Capital expenditures 0.00000M 0.00436M 0.00000M 0.00522M 0.10M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.11M 0.19M 0.65M 0.50M 0.28M
Stock based compensation - 0.00000M 0.01M 0.00000M 0.02M
Other non cash items 0.65M 0.29M 0.23M 0.19M 0.31M
Free cash flow -0.38329M -0.25692M 0.08M -0.11406M -0.50900M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AQQRF
Aquarius Surgical Technologies Inc		 - -% 0.0042 - - 1.55 32.26 10.34 -3.975
ABT
Abbott Laboratories		 -0.58 0.66% 87.83 25.97 17.24 3.57 3.20 3.81 16.75
SYK
Stryker Corporation		 -3.11 1.01% 304.69 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 -0.07 0.09% 79.27 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 -0.96 2.12% 44.33 31.49 17.24 4.41 3.65 4.88 19.19

Reports Covered

Stock Research & News

View All

Profile

Aquarius Surgical Technologies Inc., through its subsidiary, Surgical Lasers Inc., engages in the development, sale, distribution, and marketing of technologies for use in surgical and other environments in Canada and the United States. It offers integrated laser-based solutions across multiple medical disciplines, including urology, gynecology, ophthalmology, thoracic, ENT, cardiovascular, and neurosurgery. The company was incorporated in 1986 and is based in Toronto, Canada.

Aquarius Surgical Technologies Inc

89 Scollard Street, Toronto, ON, Canada, M5R 1G4

Key Executives

Name Title Year Born
Mr. N. Gary Van Nest B.Com., B.Comm., M.B.A CEO & Vice Chairman 1936
Mr. Lorne Stewart MacFarlane Chief Financial Officer NA
Mr. Christopher H. Freeman Sec. NA
Mr. Lorne Stewart MacFarlane CEO & CFO NA
Mr. Brian Wagner Vice President of Sales for SLI US Inc. NA
Mr. Christopher H. Freeman Secretary NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions